3.8 Article

The transposase domain protein Metnase/SETMAR suppresses chromosomal translocations

期刊

CANCER GENETICS AND CYTOGENETICS
卷 200, 期 2, 页码 184-190

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cancergencyto.2010.04.011

关键词

-

资金

  1. National Institutes of Health (NIH) [CA92111, T32 DK0075-20, CA 100862, HL093606, CA139429, CA140442]
  2. U.S. Army [DAMD17-00-1-0295]
  3. Walther Cancer Institute
  4. IU Simon Cancer Center

向作者/读者索取更多资源

Chromosomal translocations are common in leukemia, but little is known about their mechanism. Metnase (also termed SETMAR) is a fusion of a histone methylase and transposase protein that arose specifically in primates. Transposases were thought to be extinct in primates because they would mediate deleterious DNA movement. In primates, Metnase interacts with DNA Ligase IV (Lig IV) and promotes nonhomologous end-joining (NHEJ) DNA repair. We show here that the primate-specific protein Metnase can also enhance NHEJ in murine cells and can also interact with murine Lig IV, indicating that it integrated into the preexisting NHEJ pathway after its development in primates. Significantly, expressing Metnase in murine cells significantly reduces chromosomal translocations. We propose that the fusion of the histone methylase SET domain and the transposase domain in the anthropoid lineage to form primate Metnase promotes accurate intrachromosomal NHEJ and thereby suppresses interchromosomal translocations. Metnase may have been selected for because it has a function opposing transposases and may thus play a key role in suppressing translocations that underlie oncogenicity. (C) 2010 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据